An important role for autoimmunity in the immunopathogenesis of chronic allograft rejection

Int J Immunogenet. 2012 Oct;39(5):373-80. doi: 10.1111/j.1744-313X.2012.01112.x. Epub 2012 Apr 10.

Abstract

Organ transplantation is the treatment of choice for patients with end-stage organ dysfunction. In spite of advances in understanding of donor and recipient physiology, organ preservation, operative techniques and immunosuppression, long-term graft survival still remains a major problem primarily due to chronic rejection. Alloimmune responses to mismatched major histocompatibility antigens have been implicated as an important factor leading to rejection. However, there is increasing evidence pointing towards cross-talk between the alloimmune and autoimmune responses creating a local inflammatory milieu, which eventually leads to fibrosis and occlusion of the lumen in the transplanted organ i.e. chronic rejection. In this review, we will discuss recent studies and emerging concepts for the interdependence of alloimmune and autoimmune responses in the immunopathogenesis of chronic allograft rejection. The role of autoimmunity in the development of chronic rejection is an intriguing and exciting area of research in the field of solid-organ transplantation with a significant potential to develop novel therapeutic strategies towards preventing chronic allograft rejection.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Autoantibodies / immunology
  • Autoantigens / immunology
  • Autoimmunity*
  • Cardiac Myosins / immunology
  • Graft Rejection / immunology*
  • Graft Rejection / pathology*
  • HLA Antigens / immunology
  • Humans
  • Lymphocyte Count
  • Organ Transplantation / adverse effects*
  • Organ Transplantation / pathology
  • T-Lymphocytes, Regulatory / immunology
  • Th17 Cells / immunology

Substances

  • Autoantibodies
  • Autoantigens
  • HLA Antigens
  • Cardiac Myosins